2020
Year in Review
The Biotech Connector is 7,700 sq. ft. of well-equipped wet-lab space located on Nebraska Innovation Campus. We provide incubation space and services to bioscience startups and high-growth biotech and research-based businesses.

"Nebraska Innovation Campus is thrilled to have the Biotech Connector as part of our ecosystem. The Biotech Connector companies are using this wet lab incubator space and campus resources to become sustainable entities that will positively impact the biotech efforts in Nebraska.""
Dan Duncan
Executive Director of Nebraska Innovation Campus

Synbiotic Health
PROBIOTIC AND PREBIOTIC INGREDIENTS
Synbiotic Health aims to create the premium natural Synergistic Synbiotics branded ingredients for nutrition that can promote lifelong health and wellness. In 2020, the company has continued their research and developed activities surrounding our first product launch of iVS-1, an Advance Probiotic, which has shown clinically to support gut barrier function, or support for a "leaky gut". They expect to launch commercially in early 2021.

Adjuvance Technologies
VACCINE ADJUVANT DESIGN AND MANUFACTURING
Adjuvance Technologies is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. Adjuvants are critical components that are added to many vaccines to improve the immune response. In 2020 the company completed IND enabling studies for it's first project, completed GMP manufacturing, and received NIH funding for COVID vaccine R&D.

CellGro Technologies
CELL CULTURE BIOREACTOR
CellGro has developed novel cell culture technology that is compatible with its proprietary small, personalized, disposable bioreactors. These technologies are orders of magnitude more efficient than current cell expansion technology. In 2020, the company tested its technology to study basic cell biology and biochemistry, the interaction between cell and disease-causing agents, and more recently a promising therapeutic solution for extensive and severe acute disease.


SignalRx
IMMUNO-ONCOLOGY DEVELOPMENTS
SignalRx Pharmaceuticals is a clinical stage company focused on developing effective anticancer treatments inducing the immune system to attack cancer while blocking the most important and critical cell signaling pathways that cancer cells use to proliferate, migrate, metastasize, and recruit a blood supply. In 2020, SignalRx continued to pursue unique programs targeting the combined inhibition of key pathways involved in cancer proliferation, metastasis, angiogenesis as well as immuno-oncology.

Praesens Bio
SEQUENCING DIAGNOSTICS
Praesens Bio operates at the intersection of global health technology innovation and social impact. In 2020, the company begun their work sequencing various platforms. The company is a spin off of the Praesens Foundation and aims to develop a universal next-generation sequencing (NGS)-based diagnostic that can be implemented into the mobile labs.
Founding Partners
The Biotech Connector is the result of significant public/private partnership of six major organizations





Interested in learning more or getting a tour? Get in touch here.